Surgical approach and sandwich radiotherapy for resectable rectal cancer: advantages and problems

J Surg Oncol Suppl. 1991:2:141-3. doi: 10.1002/jso.2930480530.

Abstract

One hundred and twelve patients with locally advanced adenocarcinoma of the rectum have been treated with a protocol of adjuvant radiotherapy from 1981 to 1989. Radiotherapy was administered with a "sandwich" method at a dosage of 2700 cGy preoperatively and of 1800 cGy post-operatively. Only patients in stages B and C have been considered for results. Postoperative morbidity has been 16% and postoperative mortality 2.7%. Local failure was seen in 20% of patients without significant differences by stage, location, grading and operative technique. Distant metastases were seen in 31% of patients. Five-year actuarial survival was 49% and respectively 58% in stage B and 38% in stage C (P less than 0.01). Compared with a series of historical controls treated with surgery alone, the local recurrence rate was 20% vs. 26%, the distant metastases rate was 31% vs. 38% and the five-year actuarial survival rate was 49% vs. 36% (P greater than 0.01).

MeSH terms

  • Actuarial Analysis
  • Adenocarcinoma / mortality
  • Adenocarcinoma / therapy*
  • Combined Modality Therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Postoperative Care
  • Preoperative Care
  • Radiotherapy Dosage
  • Radiotherapy, High-Energy / methods*
  • Rectal Neoplasms / mortality
  • Rectal Neoplasms / therapy*
  • Survival Rate